Detalhe da pesquisa
1.
Maintenance darunavir/ritonavir monotherapy to prevent perinatal HIV transmission, ANRS-MIE 168 MONOGEST study.
J Antimicrob Chemother
; 78(7): 1711-1722, 2023 07 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37248782
2.
Effect of Pregnancy on Unbound Raltegravir Concentrations in the ANRS 160 RalFe Trial.
Antimicrob Agents Chemother
; 64(10)2020 09 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-32661003
3.
In utero exposure to zidovudine and heart anomalies in the ANRS French perinatal cohort and the nested PRIMEVA randomized trial.
Clin Infect Dis
; 61(2): 270-80, 2015 Jul 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-25838291
4.
Population approach to analyze the pharmacokinetics of free and total lopinavir in HIV-infected pregnant women and consequences for dose adjustment.
Antimicrob Agents Chemother
; 59(9): 5727-35, 2015 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-26149996
5.
Lopinavir/ritonavir monotherapy as a nucleoside analogue-sparing strategy to prevent HIV-1 mother-to-child transmission: the ANRS 135 PRIMEVA phase 2/3 randomized trial.
Clin Infect Dis
; 57(6): 891-902, 2013 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-23766338